2020 annual financial data
Denali Therapeutics 2020 Operating margin
Denali Therapeutics 2020 operating margin with verified reported values.
Direct answer
Operating margin was 18.69%.
Operating income was 62,718,000 USD and net income was 71,136,000 USD.
Operating cash flow was 416,152,000 USD.
Get free Denali Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 335,659,000 USD
- Operating income
- 62,718,000 USD
- Net income
- 71,136,000 USD
- Operating cash flow
- 416,152,000 USD